Antigen-Specific Tolerogenic Nanoparticles for the Treatment of Autoimmune Diseases

Time: 2:00 pm
day: Day One


  • Targeted activation of the Aryl Hydrocarbon Receptor suppresses pathogenic T and B cells through induction of Tregs
  • Antigen-specific nano-liposomes induce tolerance and suppress disease in preclinical mouse models of T1D, MS, and RA
  • AhR activation by liposomes suppresses pro-inflammatory signaling pathways in tissue-resident innate immune cells